This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Mingfeng Hao
Introduction
Mingfeng Hao is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of cancer research through his innovative inventions. His work focuses on developing novel compounds that can potentially treat various proliferative diseases, including different types of cancers.
Latest Patents
Mingfeng Hao holds a patent for "Inhibitors of cyclin-dependent kinases." This invention provides novel compounds of specific formulae and their pharmaceutically acceptable derivatives. The compounds are designed to treat and prevent proliferative diseases by inhibiting the activity of cyclin-dependent kinases, which can lead to cellular apoptosis and reduced transcription in affected subjects.
Career Highlights
Mingfeng Hao is associated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research in cancer treatment. His work is crucial in the ongoing battle against various cancers, including leukemia, melanoma, and breast cancer.
Collaborations
Mingfeng Hao collaborates with notable colleagues such as Nathanael Schiander Gray and Tinghu Zhang. Their combined expertise enhances the research efforts at the Dana-Farber Cancer Institute.
Conclusion
Mingfeng Hao's innovative work in developing inhibitors of cyclin-dependent kinases represents a significant advancement in cancer treatment. His contributions are vital in the fight against proliferative diseases, showcasing the importance of research and innovation in medicine.